| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adrenal Gland Neoplasms | 28 | 2024 | 735 | 4.050 |
Why?
|
| Tomography, X-Ray Computed | 95 | 2024 | 20757 | 2.680 |
Why?
|
| Pheochromocytoma | 9 | 2024 | 328 | 2.280 |
Why?
|
| Positron-Emission Tomography | 38 | 2016 | 6668 | 2.260 |
Why?
|
| Fluorodeoxyglucose F18 | 27 | 2017 | 2054 | 1.800 |
Why?
|
| Adrenal Gland Diseases | 6 | 2016 | 141 | 1.640 |
Why?
|
| Radiography, Abdominal | 18 | 2020 | 541 | 1.450 |
Why?
|
| Tomography, Emission-Computed | 9 | 2011 | 1126 | 1.350 |
Why?
|
| Adrenal Glands | 8 | 2020 | 557 | 1.280 |
Why?
|
| Image Enhancement | 13 | 2014 | 2880 | 1.070 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 11 | 2021 | 1232 | 1.070 |
Why?
|
| Subtraction Technique | 6 | 2010 | 517 | 1.050 |
Why?
|
| Radiation Dosage | 21 | 2021 | 1967 | 1.040 |
Why?
|
| Diagnostic Imaging | 15 | 2024 | 3533 | 1.030 |
Why?
|
| Esophageal Neoplasms | 8 | 2011 | 1663 | 0.900 |
Why?
|
| Radiopharmaceuticals | 27 | 2024 | 2736 | 0.860 |
Why?
|
| Neuroendocrine Tumors | 6 | 2024 | 659 | 0.780 |
Why?
|
| Adrenocortical Carcinoma | 5 | 2023 | 88 | 0.720 |
Why?
|
| Magnetic Resonance Imaging | 40 | 2024 | 36743 | 0.590 |
Why?
|
| Male Urogenital Diseases | 2 | 2008 | 48 | 0.580 |
Why?
|
| Female Urogenital Diseases | 2 | 2008 | 57 | 0.570 |
Why?
|
| Omentum | 2 | 2013 | 168 | 0.510 |
Why?
|
| Contrast Media | 27 | 2021 | 5331 | 0.510 |
Why?
|
| Sensitivity and Specificity | 35 | 2021 | 14718 | 0.470 |
Why?
|
| Incidental Findings | 5 | 2020 | 698 | 0.440 |
Why?
|
| Neoplasm Staging | 11 | 2013 | 11221 | 0.420 |
Why?
|
| Barium Sulfate | 2 | 2012 | 180 | 0.420 |
Why?
|
| Adrenal Cortex Neoplasms | 5 | 2023 | 161 | 0.410 |
Why?
|
| Lymphoma | 2 | 2013 | 1897 | 0.410 |
Why?
|
| Radiation Protection | 5 | 2011 | 428 | 0.400 |
Why?
|
| Abdomen | 7 | 2020 | 1137 | 0.400 |
Why?
|
| Gastrointestinal Diseases | 3 | 2022 | 1207 | 0.380 |
Why?
|
| Iopamidol | 7 | 2015 | 187 | 0.370 |
Why?
|
| Image Processing, Computer-Assisted | 15 | 2021 | 9016 | 0.370 |
Why?
|
| Choledochal Cyst | 1 | 2010 | 25 | 0.360 |
Why?
|
| Diagnosis, Differential | 30 | 2022 | 13000 | 0.360 |
Why?
|
| Pelvis | 5 | 2014 | 736 | 0.360 |
Why?
|
| Polypropylenes | 1 | 2010 | 63 | 0.350 |
Why?
|
| Pancreatic Diseases | 1 | 2012 | 354 | 0.340 |
Why?
|
| Adenoma | 6 | 2023 | 2159 | 0.340 |
Why?
|
| Gallbladder Diseases | 1 | 2010 | 139 | 0.330 |
Why?
|
| Liver Neoplasms | 12 | 2022 | 4362 | 0.320 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2013 | 957 | 0.310 |
Why?
|
| Polyps | 1 | 2010 | 200 | 0.310 |
Why?
|
| Surgical Mesh | 2 | 2014 | 315 | 0.310 |
Why?
|
| Pancreas | 2 | 2012 | 1700 | 0.310 |
Why?
|
| Hamartoma | 1 | 2010 | 236 | 0.310 |
Why?
|
| Humans | 169 | 2024 | 767998 | 0.300 |
Why?
|
| Hernia, Inguinal | 1 | 2010 | 224 | 0.290 |
Why?
|
| Pancreatic Neoplasms | 8 | 2024 | 5447 | 0.290 |
Why?
|
| Esophageal Diseases | 1 | 2008 | 167 | 0.280 |
Why?
|
| Artifacts | 8 | 2014 | 1923 | 0.270 |
Why?
|
| Kidney Neoplasms | 5 | 2022 | 4283 | 0.270 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 707 | 0.270 |
Why?
|
| Radiology | 8 | 2022 | 2104 | 0.270 |
Why?
|
| Radiographic Image Enhancement | 7 | 2015 | 877 | 0.270 |
Why?
|
| Adipose Tissue, Brown | 1 | 2012 | 776 | 0.260 |
Why?
|
| Medical Oncology | 2 | 2008 | 2341 | 0.250 |
Why?
|
| Male | 101 | 2022 | 364638 | 0.250 |
Why?
|
| Female | 103 | 2022 | 397102 | 0.240 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2008 | 2196 | 0.240 |
Why?
|
| Spermatic Cord | 1 | 2004 | 23 | 0.240 |
Why?
|
| Ovarian Neoplasms | 2 | 2013 | 4915 | 0.230 |
Why?
|
| Middle Aged | 74 | 2022 | 223422 | 0.230 |
Why?
|
| Myelolipoma | 2 | 2024 | 14 | 0.230 |
Why?
|
| Genital Neoplasms, Male | 1 | 2004 | 68 | 0.230 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2006 | 152 | 0.230 |
Why?
|
| Practice Guidelines as Topic | 9 | 2014 | 7439 | 0.230 |
Why?
|
| Abdomen, Acute | 4 | 2014 | 122 | 0.230 |
Why?
|
| Adrenal Medulla | 1 | 2003 | 56 | 0.230 |
Why?
|
| Tomography, Spiral Computed | 4 | 2006 | 273 | 0.220 |
Why?
|
| Aged | 64 | 2022 | 171453 | 0.220 |
Why?
|
| Liver Diseases | 2 | 2010 | 1305 | 0.220 |
Why?
|
| Biopsy | 8 | 2013 | 6786 | 0.220 |
Why?
|
| Water | 1 | 2009 | 1421 | 0.210 |
Why?
|
| Adenocarcinoma | 6 | 2011 | 6372 | 0.200 |
Why?
|
| Intestinal Diseases | 1 | 2007 | 505 | 0.200 |
Why?
|
| Colorectal Neoplasms | 5 | 2012 | 6973 | 0.180 |
Why?
|
| Retrospective Studies | 35 | 2022 | 81748 | 0.180 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2004 | 594 | 0.170 |
Why?
|
| Leiomyosarcoma | 1 | 2004 | 426 | 0.170 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2001 | 234 | 0.170 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2007 | 794 | 0.170 |
Why?
|
| Tracheobronchomegaly | 1 | 1999 | 5 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2011 | 10096 | 0.170 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2013 | 9412 | 0.160 |
Why?
|
| Chi-Square Distribution | 5 | 2013 | 3433 | 0.150 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2021 | 208 | 0.150 |
Why?
|
| Cysts | 1 | 2023 | 685 | 0.150 |
Why?
|
| Esophagectomy | 3 | 2011 | 478 | 0.150 |
Why?
|
| World Health Organization | 1 | 2024 | 1328 | 0.140 |
Why?
|
| Adult | 65 | 2022 | 223577 | 0.140 |
Why?
|
| Decision Making, Computer-Assisted | 2 | 2008 | 146 | 0.140 |
Why?
|
| Necrosis | 1 | 2022 | 1616 | 0.140 |
Why?
|
| Carcinoma | 1 | 2009 | 2330 | 0.140 |
Why?
|
| Biopsy, Needle | 3 | 2011 | 1622 | 0.140 |
Why?
|
| Cushing Syndrome | 2 | 2010 | 241 | 0.140 |
Why?
|
| Statistics, Nonparametric | 8 | 2010 | 2854 | 0.130 |
Why?
|
| Colonic Polyps | 3 | 2012 | 557 | 0.130 |
Why?
|
| Kidney Calculi | 2 | 2015 | 458 | 0.130 |
Why?
|
| Prostate | 2 | 2002 | 1765 | 0.130 |
Why?
|
| Radiology Information Systems | 4 | 2008 | 533 | 0.130 |
Why?
|
| Intussusception | 2 | 2008 | 116 | 0.130 |
Why?
|
| Combined Modality Therapy | 7 | 2011 | 8536 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2008 | 4050 | 0.130 |
Why?
|
| ROC Curve | 6 | 2011 | 3628 | 0.130 |
Why?
|
| Diagnostic Errors | 3 | 2009 | 1280 | 0.130 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2004 | 1164 | 0.120 |
Why?
|
| Radiography | 7 | 2008 | 6981 | 0.120 |
Why?
|
| Analysis of Variance | 4 | 2012 | 6225 | 0.120 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2022 | 2333 | 0.120 |
Why?
|
| Tomography Scanners, X-Ray Computed | 2 | 2006 | 171 | 0.120 |
Why?
|
| Colonic Neoplasms | 3 | 2022 | 2540 | 0.120 |
Why?
|
| Natural Language Processing | 3 | 2008 | 1203 | 0.120 |
Why?
|
| Reproducibility of Results | 10 | 2012 | 20218 | 0.120 |
Why?
|
| Thoracic Vertebrae | 1 | 1999 | 613 | 0.120 |
Why?
|
| Aged, 80 and over | 27 | 2020 | 59600 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2022 | 3187 | 0.120 |
Why?
|
| Hepatitis B virus | 2 | 2005 | 532 | 0.110 |
Why?
|
| Radiation Injuries | 3 | 2008 | 1198 | 0.110 |
Why?
|
| Risk Assessment | 6 | 2011 | 24317 | 0.110 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2012 | 170 | 0.110 |
Why?
|
| Appendicitis | 3 | 2011 | 691 | 0.110 |
Why?
|
| Peptic Ulcer Perforation | 1 | 1993 | 23 | 0.110 |
Why?
|
| Sarcoma | 1 | 2004 | 1804 | 0.110 |
Why?
|
| Phantoms, Imaging | 5 | 2014 | 2512 | 0.110 |
Why?
|
| Algorithms | 9 | 2021 | 14163 | 0.110 |
Why?
|
| Cholecystitis | 1 | 2014 | 181 | 0.110 |
Why?
|
| 3-Iodobenzylguanidine | 2 | 2012 | 115 | 0.100 |
Why?
|
| Spinal Neoplasms | 1 | 1999 | 715 | 0.100 |
Why?
|
| Preoperative Care | 4 | 2012 | 2255 | 0.100 |
Why?
|
| Stomach Ulcer | 1 | 1993 | 118 | 0.100 |
Why?
|
| Systems Integration | 1 | 2014 | 430 | 0.100 |
Why?
|
| Jaundice | 1 | 2013 | 95 | 0.100 |
Why?
|
| Predictive Value of Tests | 10 | 2013 | 15443 | 0.100 |
Why?
|
| Radiation Effects | 1 | 2011 | 73 | 0.100 |
Why?
|
| Insulinoma | 1 | 2012 | 121 | 0.100 |
Why?
|
| Administration, Oral | 2 | 2010 | 4030 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2001 | 2463 | 0.100 |
Why?
|
| Fats | 1 | 2012 | 99 | 0.100 |
Why?
|
| Observer Variation | 7 | 2015 | 2618 | 0.090 |
Why?
|
| Adenomatous Polyps | 1 | 2012 | 109 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 5 | 2020 | 4063 | 0.090 |
Why?
|
| Radiometry | 3 | 2007 | 819 | 0.090 |
Why?
|
| Oral Health | 1 | 2016 | 493 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 4 | 2011 | 2903 | 0.090 |
Why?
|
| Emphysema | 1 | 1993 | 236 | 0.090 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2007 | 1126 | 0.090 |
Why?
|
| Adrenocortical Adenoma | 1 | 2010 | 46 | 0.090 |
Why?
|
| Angiography | 4 | 2008 | 1597 | 0.090 |
Why?
|
| Cholestasis | 1 | 2013 | 385 | 0.080 |
Why?
|
| Intestinal Neoplasms | 1 | 2012 | 314 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2011 | 6843 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1996 | 1367 | 0.080 |
Why?
|
| Puerperal Disorders | 1 | 2012 | 304 | 0.080 |
Why?
|
| Biliary Tract Diseases | 1 | 2010 | 159 | 0.080 |
Why?
|
| Ultrasonography | 5 | 2010 | 6004 | 0.080 |
Why?
|
| 18-Hydroxycorticosterone | 1 | 2008 | 3 | 0.080 |
Why?
|
| Prospective Studies | 12 | 2020 | 54921 | 0.080 |
Why?
|
| Fluorine Radioisotopes | 1 | 2012 | 425 | 0.080 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2016 | 1374 | 0.080 |
Why?
|
| Pancreatic Cyst | 2 | 2011 | 372 | 0.080 |
Why?
|
| Hodgkin Disease | 1 | 2016 | 1383 | 0.080 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2008 | 42 | 0.080 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2010 | 154 | 0.080 |
Why?
|
| Gadolinium | 3 | 2008 | 965 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1377 | 0.070 |
Why?
|
| Ganglioneuroma | 1 | 2008 | 53 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2010 | 15831 | 0.070 |
Why?
|
| Body Weight | 3 | 2010 | 4628 | 0.070 |
Why?
|
| Neoplasm Metastasis | 3 | 2008 | 4904 | 0.070 |
Why?
|
| Pancreatitis | 1 | 2014 | 1087 | 0.070 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 520 | 0.070 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 419 | 0.070 |
Why?
|
| Area Under Curve | 2 | 2008 | 1642 | 0.070 |
Why?
|
| Automation | 2 | 2011 | 589 | 0.070 |
Why?
|
| Lingual Thyroid | 1 | 2007 | 7 | 0.070 |
Why?
|
| Health Planning Guidelines | 1 | 2008 | 152 | 0.070 |
Why?
|
| Colon, Sigmoid | 1 | 2007 | 124 | 0.070 |
Why?
|
| Esophagitis | 1 | 2008 | 164 | 0.070 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2007 | 95 | 0.070 |
Why?
|
| Molecular Weight | 1 | 2009 | 2173 | 0.070 |
Why?
|
| Radiation Monitoring | 1 | 2008 | 106 | 0.070 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2011 | 388 | 0.070 |
Why?
|
| Pregnancy Complications | 3 | 2007 | 2971 | 0.070 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2012 | 1140 | 0.070 |
Why?
|
| Esophagogastric Junction | 1 | 2009 | 350 | 0.070 |
Why?
|
| Prostatic Neoplasms | 3 | 2010 | 11101 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2012 | 1216 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 1995 | 1403 | 0.060 |
Why?
|
| Lymphatic Metastasis | 2 | 2013 | 2908 | 0.060 |
Why?
|
| Tumor Burden | 2 | 2008 | 1904 | 0.060 |
Why?
|
| Viscera | 1 | 2006 | 138 | 0.060 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2006 | 100 | 0.060 |
Why?
|
| Iohexol | 1 | 2006 | 205 | 0.060 |
Why?
|
| Collagen | 1 | 2014 | 2641 | 0.060 |
Why?
|
| False Negative Reactions | 1 | 2006 | 571 | 0.060 |
Why?
|
| Antigens, CD34 | 3 | 1996 | 657 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 2012 | 895 | 0.060 |
Why?
|
| Hepatectomy | 2 | 2005 | 588 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2008 | 1196 | 0.060 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2006 | 260 | 0.060 |
Why?
|
| Living Donors | 2 | 2006 | 648 | 0.060 |
Why?
|
| Health Status Disparities | 1 | 2016 | 1885 | 0.060 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2004 | 20 | 0.060 |
Why?
|
| Radiology Department, Hospital | 2 | 2008 | 409 | 0.060 |
Why?
|
| Pituitary Apoplexy | 1 | 2004 | 29 | 0.060 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 1798 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2006 | 962 | 0.060 |
Why?
|
| Ureteral Calculi | 1 | 2005 | 111 | 0.060 |
Why?
|
| Tongue | 1 | 2007 | 406 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 3618 | 0.050 |
Why?
|
| Patient Selection | 2 | 2008 | 4258 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2007 | 751 | 0.050 |
Why?
|
| Body Weights and Measures | 1 | 2003 | 208 | 0.050 |
Why?
|
| Prevalence | 3 | 2022 | 15867 | 0.050 |
Why?
|
| Adolescent | 10 | 2020 | 89154 | 0.050 |
Why?
|
| Neoplasms | 6 | 2013 | 22369 | 0.050 |
Why?
|
| Colonoscopy | 3 | 2012 | 1409 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2008 | 830 | 0.050 |
Why?
|
| Leukemia, Lymphoid | 1 | 1983 | 311 | 0.050 |
Why?
|
| Pentetic Acid | 1 | 2002 | 209 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
| Feasibility Studies | 4 | 2008 | 5314 | 0.050 |
Why?
|
| Urinary Calculi | 1 | 2002 | 81 | 0.050 |
Why?
|
| Bone Marrow | 4 | 2001 | 2935 | 0.050 |
Why?
|
| Hip Prosthesis | 2 | 2005 | 924 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
| Edema | 2 | 2010 | 765 | 0.050 |
Why?
|
| Cisplatin | 1 | 2008 | 1658 | 0.050 |
Why?
|
| Rectal Neoplasms | 1 | 2011 | 1183 | 0.050 |
Why?
|
| Models, Structural | 1 | 2002 | 340 | 0.050 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2006 | 524 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2016 | 3389 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2008 | 6338 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2010 | 1162 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 984 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 1999 | 5197 | 0.050 |
Why?
|
| Kidney Transplantation | 2 | 2007 | 4271 | 0.050 |
Why?
|
| Colonic Diseases | 1 | 2003 | 204 | 0.050 |
Why?
|
| Drainage | 1 | 2007 | 1183 | 0.050 |
Why?
|
| Megacolon | 1 | 2000 | 11 | 0.050 |
Why?
|
| Kidney | 2 | 2007 | 7067 | 0.050 |
Why?
|
| Urography | 1 | 2002 | 316 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2007 | 836 | 0.050 |
Why?
|
| Nephrectomy | 1 | 2006 | 930 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 3780 | 0.050 |
Why?
|
| Hepatitis B, Chronic | 1 | 2005 | 413 | 0.050 |
Why?
|
| CD40 Ligand | 1 | 2003 | 528 | 0.050 |
Why?
|
| Phlebography | 1 | 2002 | 326 | 0.050 |
Why?
|
| Sialoglycoproteins | 2 | 1992 | 316 | 0.040 |
Why?
|
| Pseudopseudohypoparathyroidism | 1 | 2000 | 8 | 0.040 |
Why?
|
| Survival Rate | 3 | 2010 | 12827 | 0.040 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 1642 | 0.040 |
Why?
|
| Sex Factors | 2 | 2012 | 10629 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11068 | 0.040 |
Why?
|
| Cicatrix | 1 | 2006 | 798 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3472 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2003 | 1151 | 0.040 |
Why?
|
| Hemangioma | 1 | 2005 | 727 | 0.040 |
Why?
|
| Calcaneus | 1 | 2002 | 144 | 0.040 |
Why?
|
| Liver Transplantation | 2 | 2010 | 2403 | 0.040 |
Why?
|
| Selection Bias | 1 | 2002 | 360 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2007 | 1172 | 0.040 |
Why?
|
| Leprosy, Tuberculoid | 1 | 1999 | 15 | 0.040 |
Why?
|
| Laparotomy | 2 | 2020 | 459 | 0.040 |
Why?
|
| Endoscopy | 1 | 2010 | 1854 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2005 | 1443 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2004 | 542 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 1983 | 381 | 0.040 |
Why?
|
| Pelvic Bones | 1 | 2002 | 274 | 0.040 |
Why?
|
| Porins | 1 | 1999 | 78 | 0.040 |
Why?
|
| Leg | 1 | 2004 | 1088 | 0.040 |
Why?
|
| Pulmonary Ventilation | 1 | 2001 | 374 | 0.040 |
Why?
|
| Neisseria meningitidis | 1 | 1999 | 111 | 0.040 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 13500 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 1996 | 9614 | 0.040 |
Why?
|
| Hyperaldosteronism | 1 | 2002 | 252 | 0.040 |
Why?
|
| Liver | 2 | 2005 | 7575 | 0.040 |
Why?
|
| Transcription Factors | 2 | 1996 | 12165 | 0.040 |
Why?
|
| Urinary Tract | 1 | 2002 | 305 | 0.040 |
Why?
|
| Bone Marrow Diseases | 1 | 2001 | 234 | 0.040 |
Why?
|
| Urologic Neoplasms | 1 | 2002 | 314 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1055 | 0.040 |
Why?
|
| von Hippel-Lindau Disease | 1 | 1999 | 154 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 1276 | 0.040 |
Why?
|
| Recurrence | 1 | 2010 | 8507 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 13658 | 0.040 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2004 | 1429 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 2 | 2011 | 463 | 0.040 |
Why?
|
| Workplace | 1 | 2004 | 873 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2007 | 2385 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 1999 | 400 | 0.030 |
Why?
|
| Intestines | 1 | 2006 | 1908 | 0.030 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 4 | 1996 | 892 | 0.030 |
Why?
|
| Bone Neoplasms | 3 | 2010 | 2564 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2011 | 65360 | 0.030 |
Why?
|
| Health Education, Dental | 1 | 2016 | 26 | 0.030 |
Why?
|
| Fluoridation | 1 | 2016 | 29 | 0.030 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1999 | 582 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1999 | 921 | 0.030 |
Why?
|
| Personhood | 1 | 2016 | 31 | 0.030 |
Why?
|
| Incidence | 3 | 2010 | 21533 | 0.030 |
Why?
|
| Scotland | 1 | 2016 | 142 | 0.030 |
Why?
|
| Carotid Artery Diseases | 1 | 2003 | 879 | 0.030 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1991 | 686 | 0.030 |
Why?
|
| Freedom | 1 | 2016 | 69 | 0.030 |
Why?
|
| Mass Screening | 2 | 2010 | 5458 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2006 | 1481 | 0.030 |
Why?
|
| Neuroblastoma | 2 | 2002 | 1266 | 0.030 |
Why?
|
| Urinary Tract Infections | 1 | 2002 | 804 | 0.030 |
Why?
|
| Immunomagnetic Separation | 1 | 1996 | 78 | 0.030 |
Why?
|
| Massachusetts | 1 | 2009 | 8893 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 4 | 1996 | 3409 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 1996 | 631 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 1996 | 433 | 0.030 |
Why?
|
| Risk Factors | 5 | 2011 | 74938 | 0.030 |
Why?
|
| Receptors, Immunologic | 2 | 1992 | 1418 | 0.030 |
Why?
|
| Quality Control | 2 | 2008 | 836 | 0.030 |
Why?
|
| Social Values | 1 | 2016 | 224 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 2 | 1992 | 116 | 0.030 |
Why?
|
| Knee Injuries | 1 | 2000 | 495 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 1996 | 792 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2006 | 2042 | 0.030 |
Why?
|
| Interleukin-3 | 2 | 1996 | 425 | 0.030 |
Why?
|
| Spine | 1 | 2002 | 1140 | 0.030 |
Why?
|
| Software | 2 | 2015 | 4479 | 0.030 |
Why?
|
| Critical Care | 1 | 2007 | 2715 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2011 | 1788 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39340 | 0.030 |
Why?
|
| Etoposide | 1 | 1996 | 640 | 0.030 |
Why?
|
| Hematopoiesis | 2 | 1996 | 2059 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2012 | 22286 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2003 | 1904 | 0.030 |
Why?
|
| Diverticulum | 1 | 2015 | 137 | 0.030 |
Why?
|
| Neutropenia | 2 | 1996 | 892 | 0.030 |
Why?
|
| Mouth Diseases | 1 | 2016 | 239 | 0.030 |
Why?
|
| Radiotherapy, High-Energy | 1 | 1994 | 228 | 0.030 |
Why?
|
| Colon | 1 | 2002 | 1800 | 0.030 |
Why?
|
| Personal Autonomy | 1 | 2016 | 316 | 0.030 |
Why?
|
| Neisseria gonorrhoeae | 2 | 1999 | 249 | 0.030 |
Why?
|
| Portal Vein | 2 | 2007 | 435 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2000 | 807 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 1321 | 0.030 |
Why?
|
| Hip Joint | 1 | 2000 | 1018 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2007 | 2442 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3210 | 0.030 |
Why?
|
| Peritoneal Diseases | 1 | 1993 | 76 | 0.030 |
Why?
|
| Hypertension | 3 | 2010 | 8616 | 0.020 |
Why?
|
| Lipids | 1 | 2023 | 3342 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2002 | 2589 | 0.020 |
Why?
|
| Blast Crisis | 1 | 1992 | 102 | 0.020 |
Why?
|
| Paresthesia | 1 | 2012 | 160 | 0.020 |
Why?
|
| Immunoconjugates | 1 | 1999 | 975 | 0.020 |
Why?
|
| Laxatives | 1 | 2012 | 95 | 0.020 |
Why?
|
| Bone Density | 2 | 2002 | 3573 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 9493 | 0.020 |
Why?
|
| Social Justice | 1 | 2016 | 487 | 0.020 |
Why?
|
| Time Factors | 4 | 2008 | 40210 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1996 | 1742 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2024 | 3619 | 0.020 |
Why?
|
| Goals | 1 | 2016 | 717 | 0.020 |
Why?
|
| Acute Disease | 2 | 2014 | 7241 | 0.020 |
Why?
|
| Metals | 2 | 2005 | 713 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 2007 | 2000 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2016 | 718 | 0.020 |
Why?
|
| Fimbriae, Bacterial | 1 | 1991 | 138 | 0.020 |
Why?
|
| Hydrocortisone | 2 | 2010 | 1840 | 0.020 |
Why?
|
| Osteoporosis | 1 | 2000 | 1604 | 0.020 |
Why?
|
| Cyclophosphamide | 1 | 1996 | 2227 | 0.020 |
Why?
|
| Base Sequence | 3 | 1996 | 12417 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1991 | 342 | 0.020 |
Why?
|
| Hyperinsulinism | 1 | 2012 | 402 | 0.020 |
Why?
|
| Immunoglobulin M | 2 | 2007 | 1527 | 0.020 |
Why?
|
| United States | 6 | 2014 | 73033 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1991 | 435 | 0.020 |
Why?
|
| Asymptomatic Diseases | 1 | 2012 | 590 | 0.020 |
Why?
|
| Zidovudine | 1 | 1991 | 625 | 0.020 |
Why?
|
| Diatrizoate Meglumine | 1 | 2008 | 79 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6119 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2017 | 8740 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 1996 | 1667 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1991 | 404 | 0.020 |
Why?
|
| Prognosis | 1 | 2009 | 29984 | 0.020 |
Why?
|
| Child, Preschool | 6 | 2016 | 42665 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1996 | 17617 | 0.020 |
Why?
|
| Synaptophysin | 1 | 2008 | 138 | 0.020 |
Why?
|
| Thrombocytopenia | 1 | 1996 | 1178 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2010 | 619 | 0.020 |
Why?
|
| Pancreatectomy | 1 | 2012 | 825 | 0.020 |
Why?
|
| Binding Sites | 1 | 1996 | 6022 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 1991 | 1252 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1996 | 2881 | 0.020 |
Why?
|
| Iodine Compounds | 1 | 2007 | 28 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 1996 | 5717 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 5798 | 0.020 |
Why?
|
| Glycine | 1 | 1991 | 672 | 0.020 |
Why?
|
| Sodium Pertechnetate Tc 99m | 1 | 2007 | 54 | 0.020 |
Why?
|
| Proteins | 2 | 1992 | 6009 | 0.020 |
Why?
|
| Interferon Type I | 1 | 1991 | 569 | 0.020 |
Why?
|
| Practice Management, Medical | 1 | 2008 | 191 | 0.020 |
Why?
|
| Solubility | 2 | 2003 | 1083 | 0.020 |
Why?
|
| Renal Veins | 1 | 2006 | 103 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 1130 | 0.020 |
Why?
|
| Pyridoxal Phosphate | 1 | 2005 | 123 | 0.020 |
Why?
|
| Vision Disorders | 1 | 2012 | 1093 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1991 | 1752 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2011 | 1070 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 1836 | 0.020 |
Why?
|
| Pregnancy | 4 | 2011 | 30244 | 0.010 |
Why?
|
| Edetic Acid | 1 | 2005 | 278 | 0.010 |
Why?
|
| Child | 7 | 2016 | 80905 | 0.010 |
Why?
|
| Office Automation | 1 | 2004 | 14 | 0.010 |
Why?
|
| Renal Artery | 1 | 2006 | 355 | 0.010 |
Why?
|
| Absorptiometry, Photon | 2 | 2002 | 1758 | 0.010 |
Why?
|
| Asthenopia | 1 | 2004 | 12 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2816 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2006 | 287 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2015 | 2101 | 0.010 |
Why?
|
| Hepatic Veins | 1 | 2004 | 112 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2004 | 221 | 0.010 |
Why?
|
| Man-Machine Systems | 1 | 2004 | 42 | 0.010 |
Why?
|
| Computer Terminals | 1 | 2004 | 41 | 0.010 |
Why?
|
| Interior Design and Furnishings | 1 | 2004 | 34 | 0.010 |
Why?
|
| Cells, Cultured | 6 | 1996 | 19015 | 0.010 |
Why?
|
| Health Promotion | 1 | 2016 | 2210 | 0.010 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 2004 | 59 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2004 | 158 | 0.010 |
Why?
|
| Lamivudine | 1 | 2005 | 367 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1999 | 10264 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2006 | 737 | 0.010 |
Why?
|
| Kidney Pelvis | 1 | 2005 | 191 | 0.010 |
Why?
|
| Health Policy | 1 | 2016 | 2698 | 0.010 |
Why?
|
| Ureter | 1 | 2006 | 364 | 0.010 |
Why?
|
| Logistic Models | 2 | 2008 | 13289 | 0.010 |
Why?
|
| Reference Values | 2 | 2001 | 4938 | 0.010 |
Why?
|
| Neutrophils | 1 | 1996 | 3786 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 2004 | 232 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2015 | 3573 | 0.010 |
Why?
|
| Stem Cells | 1 | 1996 | 3537 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1991 | 1966 | 0.010 |
Why?
|
| Probability | 1 | 2008 | 2479 | 0.010 |
Why?
|
| Lung | 1 | 2001 | 10096 | 0.010 |
Why?
|
| Manganese | 1 | 2005 | 394 | 0.010 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 2002 | 136 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 15597 | 0.010 |
Why?
|
| Computer Systems | 1 | 2004 | 469 | 0.010 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2004 | 152 | 0.010 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2005 | 620 | 0.010 |
Why?
|
| Culture Media | 2 | 1996 | 898 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2008 | 1480 | 0.010 |
Why?
|
| Lighting | 1 | 2004 | 210 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1991 | 1399 | 0.010 |
Why?
|
| Hypokalemia | 1 | 2002 | 152 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 372 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2010 | 1388 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2002 | 9116 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 2 | 1992 | 260 | 0.010 |
Why?
|
| Diarrhea | 1 | 2007 | 1320 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26418 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2010 | 41753 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1983 | 1625 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 3415 | 0.010 |
Why?
|
| Cell Separation | 2 | 1996 | 1729 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 1992 | 299 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2001 | 439 | 0.010 |
Why?
|
| Renin | 1 | 2002 | 647 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2001 | 277 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8750 | 0.010 |
Why?
|
| Fever | 1 | 2007 | 1613 | 0.010 |
Why?
|
| Random Allocation | 1 | 2004 | 2396 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 3553 | 0.010 |
Why?
|
| Posture | 1 | 2004 | 957 | 0.010 |
Why?
|
| Stereotaxic Techniques | 1 | 2002 | 553 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2011 | 3965 | 0.010 |
Why?
|
| Respiration | 1 | 2006 | 1661 | 0.010 |
Why?
|
| Ulnar Nerve | 1 | 1999 | 104 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 1159 | 0.010 |
Why?
|
| Young Adult | 2 | 2020 | 60050 | 0.010 |
Why?
|
| Colitis | 1 | 2007 | 1240 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1134 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 10757 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2003 | 1587 | 0.010 |
Why?
|
| Age Factors | 2 | 2008 | 18405 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 1926 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2005 | 2125 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1999 | 228 | 0.010 |
Why?
|
| Diffusion | 1 | 2000 | 814 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2007 | 1323 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2008 | 6517 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2010 | 2295 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2001 | 1498 | 0.010 |
Why?
|
| Aldosterone | 1 | 2002 | 881 | 0.010 |
Why?
|
| Virus Replication | 1 | 2005 | 2458 | 0.010 |
Why?
|
| Genetic Variation | 2 | 2004 | 6612 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2009 | 26377 | 0.010 |
Why?
|
| Diabetes, Gestational | 1 | 2006 | 1263 | 0.010 |
Why?
|
| Thiotepa | 1 | 1996 | 66 | 0.010 |
Why?
|
| Infant | 3 | 2008 | 36533 | 0.010 |
Why?
|
| Mutation | 2 | 2011 | 30214 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1992 | 3626 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2007 | 3216 | 0.010 |
Why?
|
| Equipment Design | 1 | 2004 | 3522 | 0.010 |
Why?
|
| Occupational Diseases | 1 | 2004 | 1457 | 0.010 |
Why?
|
| Leukapheresis | 1 | 1996 | 150 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2003 | 859 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 2004 | 1322 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2008 | 2787 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1999 | 1392 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1983 | 4857 | 0.010 |
Why?
|
| Pneumatosis Cystoides Intestinalis | 1 | 1994 | 31 | 0.010 |
Why?
|
| Melphalan | 1 | 1996 | 421 | 0.010 |
Why?
|
| Tibia | 1 | 2000 | 1075 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 12536 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1994 | 512 | 0.010 |
Why?
|
| Carboplatin | 1 | 1996 | 791 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2004 | 2076 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1983 | 6314 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2012 | 6875 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2008 | 8082 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 1999 | 21209 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2001 | 1946 | 0.010 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1992 | 98 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1991 | 305 | 0.010 |
Why?
|
| Adenovirus Early Proteins | 1 | 1991 | 58 | 0.010 |
Why?
|
| Stem Cell Factor | 1 | 1992 | 194 | 0.010 |
Why?
|
| Registries | 1 | 2008 | 8377 | 0.010 |
Why?
|
| Tamoxifen | 1 | 1996 | 966 | 0.010 |
Why?
|
| Knee Joint | 1 | 2000 | 1683 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1991 | 133 | 0.010 |
Why?
|
| Fimbriae Proteins | 1 | 1991 | 133 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1991 | 321 | 0.010 |
Why?
|
| Vero Cells | 1 | 1991 | 486 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 1991 | 211 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1992 | 605 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12075 | 0.010 |
Why?
|
| Doxorubicin | 1 | 1996 | 2234 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1991 | 943 | 0.000 |
Why?
|
| Immunocompromised Host | 1 | 1994 | 863 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1991 | 828 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1999 | 4035 | 0.000 |
Why?
|
| Hemorrhage | 1 | 2001 | 3467 | 0.000 |
Why?
|
| Oligonucleotides | 1 | 1991 | 563 | 0.000 |
Why?
|
| Physical Examination | 1 | 1994 | 1263 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15944 | 0.000 |
Why?
|
| Emergencies | 1 | 1994 | 1224 | 0.000 |
Why?
|
| Interferons | 1 | 1991 | 720 | 0.000 |
Why?
|
| Immunoblotting | 1 | 1991 | 1647 | 0.000 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2599 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3740 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 4565 | 0.000 |
Why?
|
| Radiotherapy Dosage | 1 | 1994 | 2916 | 0.000 |
Why?
|
| Calcium | 1 | 2000 | 5794 | 0.000 |
Why?
|
| Drug Synergism | 1 | 1991 | 1760 | 0.000 |
Why?
|
| DNA, Bacterial | 1 | 1991 | 1478 | 0.000 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1991 | 998 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1996 | 5904 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1991 | 1598 | 0.000 |
Why?
|
| Cloning, Molecular | 1 | 1991 | 4168 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1991 | 2088 | 0.000 |
Why?
|
| Antigens, Bacterial | 1 | 1991 | 1150 | 0.000 |
Why?
|
| Cell Division | 1 | 1992 | 4473 | 0.000 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 1276 | 0.000 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 4114 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1999 | 9253 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 6515 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 13420 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1991 | 4215 | 0.000 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 7613 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1996 | 11874 | 0.000 |
Why?
|
| Animals | 2 | 1999 | 169225 | 0.000 |
Why?
|
| Mice | 1 | 1999 | 82024 | 0.000 |
Why?
|